A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AASS | Aminoadipate-semialdehyde synthase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ABAT | 4-aminobutyrate aminotransferase | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCA7 | ATP-binding cassette, sub-family A (ABC1), member 7 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ABCC11 | ATP-binding cassette, sub-family C (CFTR/MRP), member 11 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACADM | Acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ACBD5 | Acyl-CoA binding domain containing 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACKR1 | Atypical chemokine receptor 1 (Duffy blood group) | Blood group antigen proteins CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACSBG2 | Acyl-CoA synthetase bubblegum family member 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ACSF3 | Acyl-CoA synthetase family member 3 | Disease related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL4 | Acyl-CoA synthetase long-chain family member 4 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL5 | Acyl-CoA synthetase long-chain family member 5 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ACSS1 | Acyl-CoA synthetase short-chain family member 1 | Enzymes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACTN2 | Actinin, alpha 2 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
ACTR2 | ARP2 actin-related protein 2 homolog (yeast) | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ACTRT2 | Actin-related protein T2 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enriched |
ADAM12 | ADAM metallopeptidase domain 12 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ADAM17 | ADAM metallopeptidase domain 17 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ADAM2 | ADAM metallopeptidase domain 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADAM7 | ADAM metallopeptidase domain 7 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Not detected |
ADAMTS13 | ADAM metallopeptidase with thrombospondin type 1 motif, 13 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAP1 | ArfGAP with dual PH domains 1 | Predicted intracellular proteins
| | | | | Mixed |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
AHR | Aryl hydrocarbon receptor | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP8L | A kinase (PRKA) anchor protein 8-like | Predicted intracellular proteins
| | | | | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ALDH1A1 | Aldehyde dehydrogenase 1 family, member A1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
ALG2 | ALG2, alpha-1,3/1,6-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |